House Oversight and Reform Committee Is Launching A Sweeping Investigation
The House Oversight and Reform Committee is launching a sweeping investigation into the prescription drug industry’s pricing practices, a major priority of new Chairman Elijah Cummings (D-Md.).
Cummings sent letters to a dozen different companies seeking detailed information and documents about how the companies price their medications. He is billing it as one of the broadest drug pricing investigations in decades.
SOURCE ⇒ THEHILL
